SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-196961
Filing Date
2024-08-08
Accepted
2024-08-08 16:09:00
Documents
13
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d881941d8k.htm   iXBRL 8-K 35614
  Complete submission text file 0001193125-24-196961.txt   159146

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240808.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240808_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240808_pre.xml EX-101.PRE 11255
16 EXTRACTED XBRL INSTANCE DOCUMENT d881941d8k_htm.xml XML 3686
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 241188331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)